Drug Trial Radar · NCT01706198
An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma
Last checked: Nov 19, 2026Latest source record: Jan 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,233
Actual
Start
Nov 1, 2012
Primary completion
Dec 1, 2016
Study completion Dec 16, 2016
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 15, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to compare the effectiveness and safety of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate ((FF), GW685698)/25mcg Vilanterol ((VI), GW642444) or 200mcg Fluticasone Furoate ((FF), GW685698)/25mcg Vilanterol ((VI), GW642444) ) delivered once daily via a Novel Dry Powder Inhaler (NDPI) compared with the existing asthma maintenance therapy over twelve months in subjects diagnosed with asthma. This is a Phase III multi-centre, randomised open label study. Subjects who meet the eligibility criteria are randomised and will enter a 12 month treatment period.
Conditions
- Asthma
Interventions
fluticasone furoate + vilanterolDrug
once daily via a Novel Dry Powder Inhaler
inhaled corticosteroid with or without a long acting beta2-agonistDrug
ICS alone or in combination with a long acting bronchodilator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Have Either an Asthma Control Test (ACT) Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Week 24.Time frame: Baseline (Day 0) and Week 24
Locations
180 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Cadishead, Manchester, United Kingdom
GSK Investigational Site
Cheadle, United Kingdom
GSK Investigational Site
Eccles, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Eccles, Manchester, United Kingdom
GSK Investigational Site
Ellenbrook, Manchester, United Kingdom
GSK Investigational Site
Irlam, Manchester, United Kingdom
GSK Investigational Site
Irlam, Manchester, United Kingdom
GSK Investigational Site
Irlam, Manchester, United Kingdom
GSK Investigational Site
Irlam, Manchester, United Kingdom
GSK Investigational Site
Irlam, Manchester, United Kingdom
GSK Investigational Site
Irlam, Salford, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Little Hulton, Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
GSK Investigational Site
Manchester, United Kingdom
Showing 40 of 180 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.